Compounding pharmacies sales in USA will expand through 2036, with 503A pharmacies at 65.0% of pharmacy type sales in 2026. The market was valued at USD 5.60 billion in 2025, is projected to reach USD 12.79 billion by 2036 and is forecast to record a 7.8% CAGR between 2026 and 2036.